End-of-day quote
Shenzhen S.E.
23:00:00 14/05/2024 BST
|
5-day change
|
1st Jan Change
|
15.58
CNY
|
-2.93%
|
|
0.00%
|
-9.31%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
4,520
|
4,506
|
4,765
|
4,605
|
3,622
|
Enterprise Value (EV)
1 |
3,433
|
3,470
|
3,669
|
3,893
|
2,953
|
P/E ratio
|
20.3
x
|
23.1
x
|
17.1
x
|
11.5
x
|
25.7
x
|
Yield
|
1.33%
|
1.2%
|
1.81%
|
2.22%
|
0.97%
|
Capitalization / Revenue
|
3.63
x
|
2.95
x
|
2.16
x
|
1.69
x
|
1.64
x
|
EV / Revenue
|
2.76
x
|
2.27
x
|
1.66
x
|
1.43
x
|
1.34
x
|
EV / EBITDA
|
14.4
x
|
12.6
x
|
9.91
x
|
7.73
x
|
11.8
x
|
EV / FCF
|
-59.8
x
|
93.4
x
|
50.9
x
|
-15
x
|
-1,674
x
|
FCF Yield
|
-1.67%
|
1.07%
|
1.96%
|
-6.67%
|
-0.06%
|
Price to Book
|
2.61
x
|
2.41
x
|
2.25
x
|
1.91
x
|
1.51
x
|
Nbr of stocks (in thousands)
|
216,000
|
216,000
|
216,000
|
217,410
|
210,847
|
Reference price
2 |
20.93
|
20.86
|
22.06
|
21.18
|
17.18
|
Announcement Date
|
08/03/20
|
17/03/21
|
07/03/22
|
23/03/23
|
29/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,245
|
1,245
|
1,529
|
2,209
|
2,727
|
2,206
|
EBITDA
1 |
272.6
|
238.2
|
276
|
370.2
|
503.7
|
249.9
|
EBIT
1 |
219.4
|
183.8
|
206.3
|
296.6
|
427.6
|
160.2
|
Operating Margin
|
17.62%
|
14.76%
|
13.49%
|
13.43%
|
15.68%
|
7.26%
|
Earnings before Tax (EBT)
1 |
222
|
204
|
229.5
|
322.6
|
472
|
176.7
|
Net income
1 |
186.1
|
171.6
|
195.2
|
278.5
|
397.6
|
141.8
|
Net margin
|
14.95%
|
13.78%
|
12.77%
|
12.61%
|
14.58%
|
6.43%
|
EPS
2 |
1.149
|
1.031
|
0.9037
|
1.289
|
1.838
|
0.6686
|
Free Cash Flow
1 |
75.46
|
-57.37
|
37.16
|
72.03
|
-259.8
|
-1.764
|
FCF margin
|
6.06%
|
-4.61%
|
2.43%
|
3.26%
|
-9.53%
|
-0.08%
|
FCF Conversion (EBITDA)
|
27.68%
|
-
|
13.46%
|
19.46%
|
-
|
-
|
FCF Conversion (Net income)
|
40.55%
|
-
|
19.04%
|
25.87%
|
-
|
-
|
Dividend per Share
|
-
|
0.2778
|
0.2500
|
0.4000
|
0.4700
|
0.1670
|
Announcement Date
|
08/03/20
|
08/03/20
|
17/03/21
|
07/03/22
|
23/03/23
|
29/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
257
|
1,087
|
1,035
|
1,096
|
711
|
670
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
75.5
|
-57.4
|
37.2
|
72
|
-260
|
-1.76
|
ROE (net income / shareholders' equity)
|
29.5%
|
14%
|
10.8%
|
14%
|
17.7%
|
5.98%
|
ROA (Net income/ Total Assets)
|
15.9%
|
7.91%
|
6.34%
|
7.92%
|
9.78%
|
3.32%
|
Assets
1 |
1,170
|
2,171
|
3,079
|
3,516
|
4,065
|
4,269
|
Book Value Per Share
2 |
4.460
|
8.030
|
8.650
|
9.800
|
11.10
|
11.30
|
Cash Flow per Share
2 |
1.600
|
4.300
|
2.530
|
4.050
|
2.750
|
2.260
|
Capex
1 |
111
|
187
|
143
|
117
|
413
|
319
|
Capex / Sales
|
8.95%
|
15.01%
|
9.39%
|
5.29%
|
15.14%
|
14.46%
|
Announcement Date
|
08/03/20
|
08/03/20
|
17/03/21
|
07/03/22
|
23/03/23
|
29/03/24
|
|
1st Jan change
|
Capi.
|
---|
| -9.31% | 464M | | +17.16% | 66.22B | | +3.54% | 49.24B | | +18.03% | 41.4B | | +21.48% | 26.62B | | +13.22% | 19.84B | | +1.71% | 17.44B | | -11.36% | 15.92B | | -23.54% | 15.57B | | +2.57% | 15.45B |
Other Specialty Chemicals
|